The company
Rocket Pharmaceuticals, Inc.
RCKT · Nasdaq
RCKT stood above a rising 150-day average in 10 of the last 52 weekly readings, and has been out of that trend for the last 14 weeks. It is 35.7% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 14
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $69K
- Insider sales, 12 months
- $1.7M
- Officials’ trades on record
- 0
- Institutions holding
- 174 (-16)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 10 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Martin WilsonGeneral Counsel | sold | 75,364at $3.40 | 11 Sep 2026filed 15 Sep 2026 |
| Gaurav ShahCEO | sold | 2,293at $3.38 | 18 Aug 2026filed 20 Aug 2026 |
| Martin WilsonGeneral Counsel | sold | 631at $3.38 | 18 Aug 2026filed 20 Aug 2026 |
| Martin WilsonGeneral Counsel | sold | 3,493at $3.38 | 13 Aug 2026filed 17 Aug 2026 |
| Gaurav ShahCEO | sold | 2,837at $3.38 | 13 Aug 2026filed 17 Aug 2026 |
| Sarbani ChaudhuriOfficer | sold | 4,701at $3.50 | 11 Aug 2026filed 13 Aug 2026 |
| Christopher James StevensChief Operating Officer | sold | 36,658at $3.50 | 11 Aug 2026filed 13 Aug 2026 |
| Gaurav ShahCEO | sold | 55,684at $3.09 | 21 May 2026filed 26 May 2026 |
| John MilitelloOfficer | sold | 384at $3.01 | 19 May 2026filed 21 May 2026 |
| Martin WilsonGeneral Counsel | sold | 662at $3.01 | 19 May 2026filed 21 May 2026 |
| Gaurav ShahCEO | sold | 2,409at $3.01 | 19 May 2026filed 21 May 2026 |
| John MilitelloOfficer | sold | 855at $3.61 | 13 May 2026filed 14 May 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| RTW INVESTMENTS, LPunchanged · filed 14 Aug 2026 | 17,687,772$60.5M | 00.0% |
| BlackRock, Inc.added · filed 7 Aug 2026 | 9,923,962$33.9M | +2,089,167+26.7% |
| VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026 | 5,810,033$19.9M | +1,119,818+23.9% |
| CITIGROUP INCreduced · filed 3 Aug 2026 | 4,865,551$16.6M | -242,157−4.7% |
| MARSHALL WACE, LLPadded · filed 13 Aug 2026 | 4,029,262$13.8M | +990,547+32.6% |
| MILLENNIUM MANAGEMENT LLCadded · filed 14 Aug 2026 | 4,000,344$13.7M | +882,220+28.3% |
| Newtyn Management, LLCadded · filed 14 Aug 2026 | 4,000,000$13.7M | +834,100+26.3% |
| MAVERICK CAPITAL LTDadded · filed 14 Aug 2026 | 3,923,963$13.4M | +356,591+10.0% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 3,784,387$12.9M | +8,651+0.2% |
| AQR CAPITAL MANAGEMENT LLCadded · filed 14 Aug 2026 | 3,386,162$11.6M | +316,232+10.3% |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.